517
Views
5
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and immunosuppressive activity evaluation of substituted N-imidazolidin-2-ones and N-tetrahydropyrimidin-2(1H)-ones

&
Pages 659-667 | Received 20 Dec 2007, Accepted 07 May 2008, Published online: 20 Oct 2008

Figures & data

Figure 1 Structure of compound 1.

Figure 1 Structure of compound 1.

Scheme 1 Synthesis of imidazolidin-2-ones 10-17 and 33-37 and tetrahydropyrimidin-2(1H)-ones 42-45. Reaction reagents and conditions: (i) AcOH, reflux; (ii) Pd/C 5%, H2, THF, 50°C; (iii) 2-chloroethyl isocyanate, CHCl3, reflux; (iv) 2-chloroethyl isocyanate (8 éq), microwaves, 82°C, 20 W; (v) 3-chloropropyl isocyanate, CHCl3, reflux; (vi) Cs2CO3, CH3CN, reflux; (vii) Na2CO3, CH3CN, reflux.

Scheme 1 Synthesis of imidazolidin-2-ones 10-17 and 33-37 and tetrahydropyrimidin-2(1H)-ones 42-45. Reaction reagents and conditions: (i) AcOH, reflux; (ii) Pd/C 5%, H2, THF, 50°C; (iii) 2-chloroethyl isocyanate, CHCl3, reflux; (iv) 2-chloroethyl isocyanate (8 éq), microwaves, 82°C, 20 W; (v) 3-chloropropyl isocyanate, CHCl3, reflux; (vi) Cs2CO3, CH3CN, reflux; (vii) Na2CO3, CH3CN, reflux.

Figure 2 Structure of compounds 10, 11 and 14.

Figure 2 Structure of compounds 10, 11 and 14.

Table I. Inhibition of the mouse splenocyte ConA-induced proliferation by N-substituted imidazolidin-2-ones 10-17 and 33-37 and tetrahydropyrimidin-2(1H)-ones 42-45.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.